Gain Therapeutics
GANX | NASDAQ
$0.94
-$0.10 (-9.62%)
At close: Nov 16, 2026, 4:00 PM ET
$1.10
+$0.16 (+17.02%)
After-hours:
Nov 16, 2026, 6:40 PM ET
Gain Therapeutics Statistics
Key statistics explainedMarket Data
$40.1M
$29.08M
0.19
713.81K
43.77M
25.07%
20.20%
NASDAQ
US36269B1052
Price Performance
-25.4%
-53.9%
-42.0%
-70.8%
-66.7%
-65.2%
-89.8%
-25.4%
-66.8%
-35.4%
-34.3%
Valuation
-2.24
N/A
-0.06
0.07
N/A
178.20
3.95
-2.35
-2.13
-2.41
N/A
-1.65
-1.66
-1.70
-44.7%
-42.6%
-46.9%
Financial Health
$11.39M
$676.71K
$11.7M
$13.23M
5.36
5.36
0.07
-0.04
-0.04
-25.23
0.00
-6.96
4
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-10.2%
Returns
-135.9%
-133.2%
-159.0%
-163.0%
-136.6%
Historical Growth (CAGR)
-150.0%
-88.4%
N/A
47.2%
29.3%
N/A
10.9%
-2.4%
N/A
Analyst Forecasts
Buy
2
59.5%
N/A
Mar 25, 2027
-$0.10
-9.1%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$5.00
431.9%
Cash Flow
$-17.07M
$-17.07M
$-18.82M
-$0.39
-$0.39
0.0%
Income Statement
$0
$0
$-17.7M
$-17.5M
$-17.98M
-$0.42
N/A
$-856.3K
21
Add to Watchlist
Select watchlists to add or remove GANX